BioPharma Credit (LON:BPCR - Get Free Report) announced a dividend on Tuesday, March 25th, DividendData.Co.Uk reports. Investors of record on Thursday, April 3rd will be paid a dividend of $0.02 per share on Wednesday, May 7th. This represents a dividend yield of 1.99%. The ex-dividend date is Thursday, April 3rd. The official announcement can be viewed at this link.
BioPharma Credit Stock Up 1.1 %
Shares of BPCR traded up GBX 0.01 ($0.00) during mid-day trading on Friday, reaching GBX 0.89 ($0.01). The company's stock had a trading volume of 618,360 shares, compared to its average volume of 1,025,590. The company has a market cap of £1.05 billion, a price-to-earnings ratio of 10.09 and a beta of 0.22. The business has a fifty day moving average of GBX 0.86 and a 200 day moving average of GBX 0.87. BioPharma Credit has a 1 year low of GBX 0.83 ($0.01) and a 1 year high of GBX 0.94 ($0.01).
About BioPharma Credit
(
Get Free Report)
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Recommended Stories

Before you consider BioPharma Credit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.
While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.